Rep. Walden Requests FDA Briefing on Coronavirus' Impact on Drug and Medical Supplies
March 12, 2020
March 12, 2020
WASHINGTON, March 12 -- Rep. Greg Walden, R-Oregon, issued the following news release:
Representative Greg Walden (R-Hood River), Republican Leader of the Energy and Commerce Committee, joined a bipartisan group of committee members in writing to the Food and Drug Administration (FDA) Commissioner Stephen M. Hahn, M.D. asking a series of questions and requesting a briefing on the potential impact the 2019 Novel Coronavirus (COVID-19) could have on the supply of safe drugs and other . . .
Representative Greg Walden (R-Hood River), Republican Leader of the Energy and Commerce Committee, joined a bipartisan group of committee members in writing to the Food and Drug Administration (FDA) Commissioner Stephen M. Hahn, M.D. asking a series of questions and requesting a briefing on the potential impact the 2019 Novel Coronavirus (COVID-19) could have on the supply of safe drugs and other . . .